Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gout Attack”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07706777
What this trial is testing

Clinical Study of HRS-2129 for Acute Gouty Arthritis

Who this might be right for
Acute Gouty Arthritis
Shandong Suncadia Medicine Co., Ltd. 90
Large-scale testing (Phase 3)Looking for participantsNCT06863701
What this trial is testing

Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis

Who this might be right for
Gout ArthritisGout Attack
Laboratorios Silanes S.A. de C.V. 72
Early research (Phase 1)UnknownNCT04586803
What this trial is testing

Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers

Who this might be right for
Primary GoutHyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00506883
What this trial is testing

MPC-004 for the Treatment of an Acute Gout Flare

Who this might be right for
Gout
Takeda 185
Large-scale testing (Phase 3)UnknownNCT06169891
What this trial is testing

Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout

Who this might be right for
Acute Gout
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 500
Large-scale testing (Phase 3)Ended earlyNCT01362608
What this trial is testing

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Who this might be right for
Gouty Arthritis
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)UnknownNCT04462666
What this trial is testing

Oral Huzhang Granules for Acute Gouty Arthritis

Who this might be right for
Gouty Arthritis
Shanghai Yueyang Integrated Medicine Hospital 267
Not applicableUnknownNCT04069325
What this trial is testing

Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy

Who this might be right for
Gout Flare
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 72
Testing effectiveness (Phase 2)Study completedNCT00798369
What this trial is testing

Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients

Who this might be right for
Acute Gout
Novartis 200
Not applicableWithdrawnNCT04784351
What this trial is testing

Prediction of Expected Length of Hospital Stay Using Machine Learning

Who this might be right for
InfectionHeart FailureChronic Obstructive Pulmonary Disease+6 more
Brigham and Women's Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07498647
What this trial is testing

Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Who this might be right for
Gout and Hyperuricemia
BioRay Pharmaceutical Co., Ltd. 160
Large-scale testing (Phase 3)Study completedNCT05586958
What this trial is testing

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Who this might be right for
GoutHyperuricemiaGout Flare+1 more
LG Chem 354
Large-scale testing (Phase 3)Study completedNCT01029652
What this trial is testing

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study

Who this might be right for
Acute Gout
Novartis Pharmaceuticals 230
Testing effectiveness (Phase 2)Study completedNCT00663169
What this trial is testing

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Who this might be right for
Arthritis, Gouty
Novartis 6
Not applicableWithdrawnNCT01775098
What this trial is testing

Allopurinol in Acute Gout

Who this might be right for
Gout
Université de Sherbrooke
Not applicableEnded earlyNCT03621215
What this trial is testing

The Effect of Tart Cherry Juice on Risk of Gout Attacks

Who this might be right for
Gout FlareGout Attack
Sheffield Hallam University 38
Testing effectiveness (Phase 2)Study completedNCT01712204
What this trial is testing

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

Who this might be right for
Gout Flares
TWi Biotechnology, Inc. 82
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Large-scale testing (Phase 3)Study completedNCT05983445
What this trial is testing

Safety & Efffficacy of Genakumab in Patients With Frequent Flares

Who this might be right for
Acute Gout Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 313
Not applicableUnknownNCT06197828
What this trial is testing

Novel Biomarkers for Early Renal Injury in Children With Sepsis

Who this might be right for
Acute Kidney InjurySepsisGout Flare
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation